Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

8.74
Delayed Data
As of 4:00pm ET
 +0.02 / +0.23%
Today’s Change
4.72
Today|||52-Week Range
9.15
+56.07%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close8.72
Today’s open8.73
Day’s range8.61 - 8.87
Volume83,284
Average volume (3 months)127,322
Market cap$229.4M
Dividend yield--
Data as of 4:00pm ET, 08/17/2017

Growth & Valuation

Earnings growth (last year)+18.45%
Earnings growth (this year)-1.37%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+140.14%
P/E ratio--
Price/Sales5.59
Price/Book3.55

Competitors

 Today’s
change
Today’s
% change
VYGRVoyager Therapeutics...-0.08-0.92%
ONVOOrganovo Holdings In...-0.07-3.37%
TOCATocagen Inc+0.35+2.86%
ENZYEnzymotec Ltd+0.40+3.96%
Data as of 4:00pm ET, 08/17/2017

Financials

Last reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.78
Annual revenue (last year)$25.1M
Annual profit (last year)-$73.4M
Net profit margin-292.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Scott T. McMillan
Corporate headquarters
Amsterdam, Noord-holland

Forecasts